The Experimental Science Team at Dyno Therapeutics conducts cutting-edge research to develop and optimize Adeno-associated Virus (AAV) capsids using next-gen DNA technologies and machine learning. Their goal is to enhance the delivery methods for gene therapies, ensuring more effective and targeted treatments.
Adrian Veres
SVP, Experimental Science & Co...
JJ Staiti
RA II, Experimental Science
Lindsey Campion
Senior RA, Experimental Scienc...
Melanie Chin
RA II, Experimental Science
Michael Robinson
RA II, Experimental Science
Roshana Krishnamurth...
RA II, Experimental Science
Thor Breitbarth
RA II, Experimental Science
Tyanne Liu
RA II, Experimental Science
William Fassler
Research Associate
View all